Sun Pharmaceutical Industries balance sheet

As of Sep 2026

Total assets: ₹1,14,838cr+10.7% on Sep 2025
Shareholders' equity: ₹89,564cr+14.6% on Sep 2025
Total debt: ₹2,693cr−42.5% on Sep 2025
Cash and investments: ₹31,603cr+23.2% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	11,141	11,114	10,036	10,192	10,390
	1,864	1,381	1,234	1,108	963
	10,049	9,833	8,939	8,599	8,713
	12,316	11,875	3,611	4,420	5,317
	1,604	1,671	5,410	4,246	4,010
	0.0	0.0	449	443	389
	3,247	3,789	4,249	5,999	5,068
	2.9	1.8	2.8	0.9	0.6
	158	66.6	177	118	165
	3,408	3,857	4,429	6,117	5,234
	3,911	4,046	4,408	4,104	3,164
	1,279	1,116	961	2,759	2,679
	45,572	44,894	39,476	41,988	40,860
	12,592	11,493	10,243	9,868	10,513
	13,202	20,933	13,656	8,585	9,373
	17,805	15,510	13,046	11,249	11,439
	18,401	9,771	10,269	9,286	4,624
	1,967	1,833	1,063	1,235	1,147
	53.5	52.7	48.4	65.0	41.3
	1,747	1,404	1,741	917	765
	53,175	49,503	39,823	31,337	27,387
	3,499	2,865	2,528	2,228	1,962
	69,267	63,860	52,594	43,433	39,862
	30.9	30.9	30.4	41.9	21.4
	1,14,838	1,08,785	92,101	85,463	80,744
Equity
	240	240	240	240	240
	89,040	83,330	71,978	63,427	55,755
	89,280	83,570	72,218	63,667	55,995
	284	310	268	3,439	3,320
	89,564	83,880	72,486	67,106	59,315
Liabilities
	66.7	31.3	2.5	1.3	0.0
	440	992	366	302	564
	507	1,024	369	304	564
	508	512	465	414	343
	310	378	192	155	31.7
	359	370	394	500	583
	1,683	2,283	1,420	1,373	1,521
	2,627	4,050	1,867	2,844	6,198
	7,419	7,334	6,184	5,653	5,682
	2,885	2,756	2,085	1,632	1,721
	12,931	14,140	10,136	10,130	13,601
	6,934	5,944	6,155	5,358	5,354
	2,602	1,350	733	412	309
	1,125	1,188	1,170	1,084	643
	23,592	22,622	18,194	16,984	19,906
	—	—	—	0.6	0.6
	25,275	24,905	19,615	18,357	21,428
	1,14,838	1,08,785	92,101	85,463	80,744
Trade payables — MSME split
	7,419	7,334	6,184	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SUNPHARMA₹1,761.00

Sun Pharmaceutical Industries Ltd.

· Pharma & Health

₹ CrorePeersCIPLA DRREDDY LUPIN APOLLOHOSP MAXHEALTH DIVISLAB TORNTPHARM ZYDUSLIFEMcap ₹4.23L Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	10,390.4	10,192.3	10,035.9	11,114.1	11,141.2
+ Capital Work-in-Progress	963.4	1,107.7	1,234.3	1,380.7	1,863.7
+ Goodwill	8,712.7	8,599.0	8,939.4	9,833.1	10,049.4
+ Other Intangibles	5,317.0	4,420.1	3,610.9	11,875.1	12,315.7
+ Intangibles under Development	4,009.8	4,246.2	5,409.6	1,671.1	1,604.1
+ Investments (Equity Method)	389.4	442.6	448.7	0.0	0.0
+ Non-current Investments	5,068.1	5,998.6	4,249.0	3,789.1	3,247.4
+ Long-term Loans	0.6	0.9	2.8	1.8	2.9
+ Other Non-current Financial Assets	165.3	118.0	177.0	66.6	157.9
Non-current Financial Assets	5,234.0	6,117.4	4,428.8	3,857.4	3,408.2
+ Deferred Tax Assets	3,164.2	4,103.7	4,407.6	4,046.5	3,911.0
+ Other Non-current Assets	2,679.4	2,759.0	960.8	1,116.1	1,278.5
Total Non-current Assets	40,860.3	41,987.9	39,476.1	44,894.0	45,571.9
Current Assets
+ Inventories	10,513.1	9,868.3	10,243.3	11,492.9	12,592.4
+ Current Investments	9,372.6	8,584.5	13,656.1	20,933.5	13,201.8
+ Trade Receivables	11,438.5	11,249.4	13,046.1	15,509.7	17,804.8
+ Cash & Cash Equivalents	4,623.7	9,285.7	10,268.8	9,770.5	18,401.0
+ Other Bank Balances	1,146.6	1,235.0	1,062.9	1,832.6	1,967.4
+ Short-term Loans	41.3	65.0	48.4	52.7	53.5
+ Other Current Financial Assets	764.5	917.2	1,740.7	1,403.7	1,747.0
Current Financial Assets	27,387.2	31,336.8	39,822.9	49,502.6	53,175.4
+ Other Current Assets	1,961.7	2,228.0	2,527.9	2,864.8	3,498.8
Total Current Assets	39,861.9	43,433.1	52,594.1	63,860.3	69,266.6
+ Assets Held for Sale	21.4	41.9	30.4	30.9	30.9
Total Assets	80,743.6	85,462.9	92,100.6	1,08,785.2	1,14,838.4
Equity
+ Equity Share Capital	239.9	239.9	239.9	239.9	239.9
+ Other Equity / Reserves	55,755.5	63,426.8	71,978.1	83,330.2	89,040.0
Equity — Owners of Parent	55,995.4	63,666.8	72,218.0	83,570.1	89,279.9
+ Minority Interest	3,320.1	3,439.2	267.9	309.7	283.9
Total Equity	59,315.5	67,106.0	72,486.0	83,879.7	89,563.7
Liabilities
+ Borrowings — Non-current	0.0	1.3	2.5	31.3	66.7
+ Other Non-current Financial Liab	563.7	302.3	366.4	992.4	440.1
Non-current Financial Liabilities	563.7	303.6	368.9	1,023.7	506.7
+ Provisions — Non-current	342.9	413.9	465.0	512.2	507.7
+ Deferred Tax Liabilities	31.7	155.1	192.4	378.0	310.0
+ Other Non-current Liabilities	582.8	499.9	394.0	369.6	358.6
Non-current Liabilities	1,521.1	1,372.5	1,420.4	2,283.4	1,683.1
+ Borrowings — Current	6,197.9	2,844.4	1,867.1	4,050.4	2,626.8
+ Trade Payables	5,681.5	5,653.3	6,184.3	7,333.8	7,419.0
+ Other Current Financial Liab	1,721.2	1,632.4	2,084.7	2,756.3	2,885.0
Current Financial Liabilities	13,600.6	10,130.1	10,136.1	14,140.4	12,930.8
+ Provisions — Current	5,354.4	5,357.6	6,155.1	5,944.1	6,934.0
+ Current Tax Liabilities	308.7	411.7	733.2	1,350.0	2,602.3
+ Other Current Liabilities	642.7	1,084.5	1,169.8	1,187.5	1,124.6
Current Liabilities	19,906.4	16,983.8	18,194.2	22,622.0	23,591.6
+ Liabilities Held for Sale	0.6	0.6	—	—	—
Total Liabilities	21,428.1	18,356.9	19,614.6	24,905.5	25,274.7
Total Equity & Liabilities	80,743.6	85,462.9	92,100.6	1,08,785.2	1,14,838.4
Trade Payables — MSME split
+ Dues to Other Creditors — Current	—	—	6,184.3	7,333.8	7,419.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 199%.